Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Johnson & Johnson Enterprise Innovation Inc.
University of Kentucky
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Universität des Saarlandes
University of Florida
University of Virginia
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
Zhejiang Cancer Hospital
University of California, Davis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
University of Michigan Rogel Cancer Center
Royal Marsden NHS Foundation Trust
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Antoine Lacassagne
Indiana University
University of Michigan Rogel Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
University of Chicago
Fudan University
Thomas Jefferson University
Groupe Oncologie Radiotherapie Tete et Cou
Dana-Farber Cancer Institute
Sun Yat-sen University
Case Comprehensive Cancer Center
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of Colorado, Denver
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Pittsburgh
Beijing Tongren Hospital
Jules Bordet Institute
University of Chicago
University of Birmingham
Case Comprehensive Cancer Center
University of Chicago
Icahn School of Medicine at Mount Sinai
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Charite University, Berlin, Germany
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Chicago
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Xiangya Hospital of Central South University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
China Three Gorges University, Yichang, China